首页> 外文期刊>Stem cells international >Mesenchymal Stem Cell Therapy Facilitates Donor Lung Preservation by Reducing Oxidative Damage during Ischemia
【24h】

Mesenchymal Stem Cell Therapy Facilitates Donor Lung Preservation by Reducing Oxidative Damage during Ischemia

机译:间充质干细胞疗法通过降低缺血过程中的氧化损伤来促进供体肺保存

获取原文
获取原文并翻译 | 示例
           

摘要

Lung transplantation is a lifesaving therapy for people living with severe, life-threatening lung disease. The high mortality rate among patients awaiting transplantation is mainly due to the low percentage of lungs that are deemed acceptable for implantation. Thus, the current shortage of lung donors may be significantly reduced by implementing different therapeutic strategies which facilitate both organ preservation and recovery. Here, we studied whether the anti-inflammatory effect of human umbilical cord-derived mesenchymal stem cells (HUCPVCs) increases lung availability by improving organ preservation. We developed a lung preservation rat model that mimics the different stages by which donor organs must undergo before implantation. The therapeutic schema was as follows: cardiac arrest, warm ischemia (2h at room temperature), cold ischemia (1.5h at 4 degrees C, with Perfadex), and normothermic lung perfusion with ventilation (Steen solution, 1h). After 1h of warm ischemia, HUCPVCs (1 x 10(6) cells) or vehicle was infused via the pulmonary artery. Physiologic data (pressure-volume curves) were acquired right after the cardiac arrest and at the end of the perfusion. Interestingly, although lung edema did not change among groups, lung compliance dropped to 34% in the HUCPVC-treated group, while the vehicle group showed a stronger reduction (69%, p<0.0001). Histologic assessment demonstrated less overall inflammation in the HUCPVC-treated lungs. In addition, MPO activity, a neutrophil marker, was reduced by 41% compared with vehicle (p<0.01). MSC therapy significantly decreased tissue oxidative damage by controlling reactive oxygen species production. Accordingly, catalase and superoxide dismutase enzyme activities remained at baseline levels. In conclusion, these results demonstrate that the anti-inflammatory effect of MSCs protects donor lungs against ischemic injury and postulates MSC therapy as a novel tool for organ preservation.
机译:None

著录项

  • 来源
    《Stem cells international》 |2019年第5期|共1页
  • 作者单位

    Univ Favaloro CONICET Inst Med Traslac Trasplante &

    Bioingn IMeTTyB Lab Regulat Gen &

    Celulas;

    Univ Favaloro CONICET Inst Med Traslac Trasplante &

    Bioingn IMeTTyB Lab Regulat Gen &

    Celulas;

    Univ Favaloro CONICET Inst Med Traslac Trasplante &

    Bioingn IMeTTyB Lab Regulat Gen &

    Celulas;

    Univ Nacl La Plata Fac Ciencias Vet Dept Cirugia Calle 60 &

    118 RA-1900 Buenos Aires DF;

    Univ Nacl La Plata Fac Ciencias Vet Dept Cirugia Calle 60 &

    118 RA-1900 Buenos Aires DF;

    Hosp Univ Fdn Favaloro Dept Cirugia Cardiovasc &

    Torac Av Belgrano 1746 RA-1039 Buenos Aires DF;

    Univ Nacl La Plata Fac Ciencias Vet Dept Cirugia Calle 60 &

    118 RA-1900 Buenos Aires DF;

    Univ Favaloro CONICET Inst Med Traslac Trasplante &

    Bioingn IMeTTyB Lab Regulat Gen &

    Celulas;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物工程学(生物技术);
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号